Green coffee extract shaves a few points off blood pressure

High blood pressure is one of the most consequential and most modifiable health numbers a person has, and the supplement market has responded with a stream of products claiming to lower it. Green coffee bean extract is among the most heavily studied of these, and trials testing it have multiplied in recent years. With individual studies pointing in different directions and varying in dose and duration, the open question was simple: when all the trial evidence is gathered and weighed together, does green coffee bean extract actually move blood pressure, and by how much? That is the question this analysis set out to settle.

The researchers systematically searched four databases, PubMed/Medline, Scopus, the Cochrane Library and Google Scholar, for clinical trials examining the effects of green coffee supplements on systolic and diastolic blood pressure, covering the literature up to February 2019. Nine studies reported both systolic and diastolic blood pressure as outcomes and were included. For each trial, the team took the mean change and its spread in the supplement group and the control group, then pooled these to estimate the average difference between groups at follow-up. They also ran subgroup analyses by participant blood pressure status, supplement dose and trial duration.

Pooling the nine trials, green coffee bean extract lowered systolic blood pressure by 3.093 mmHg and diastolic blood pressure by 2.170 mmHg compared with control, and the individual trials agreed with each other closely on the systolic result. Those are real but modest reductions: a few points of pressure, not a transformation. The subgroup analyses sharpened the picture, finding significant reductions in both systolic and diastolic pressure specifically in studies of hypertensive patients, in studies using doses below 400 mg, and in studies administering the supplement for 4 weeks. The authors conclude the evidence supports green coffee bean extract for improving blood pressure indices.

This analysis arrives amid a proliferation of individual trials on green coffee bean extract, and its contribution is to size the effect rather than merely confirm its existence. The finding that benefits concentrate in people with hypertension fits a common pattern in blood pressure research, where those with the most room to improve tend to improve most. What the analysis cannot answer is how long the effect persists beyond the short trial durations studied, how the extract compares with established treatments or lifestyle changes, and whether the effect holds at higher doses, since the subgroup signal favoured doses under 400 mg.

If you have come across green coffee bean extract marketed for heart or metabolic health, this is the most rigorous sizing of its blood pressure effect available: a reduction of roughly three points systolic and two points diastolic on average, clearest in people who already have high blood pressure. For someone with normal pressure, the evidence here offers much less. A few points of pressure can matter at a population level, but nothing in this analysis positions the supplement as a replacement for medical treatment, and anyone managing diagnosed hypertension would be reading this as background, not as a plan.